Chuan Wang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response (NCT07129187) | Chuan Wang | 2025-10-01 |
Track Chuan Wang automatically
Every clearance here is in the API, with alerts when new ones post.